Methylation Profiling Improves the Care of Pediatric Brain Tumor Patients

Pouya Jamshidi, Matthew McCord, Craig Horbinski, Lawrence Jennings, Lucas Santana Dos Santos, Iga Alicja Fudyma, Michael DeCuypere, Kai Lee Yap, Pamela Rathbun, Nitin Wadhwani*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

We describe a pediatric patient with an intra-axial tumor; histopathologic examination of the resected specimen was unable to establish a precise diagnosis. While the initial targeted next-generation sequencing (NGS) panelwas also nondiagnostic, genomic DNA methylation profiling indicated that the tumor was an astroblastoma,MN1-altered. A more comprehensive NGS panel was then run, which confirmed an MN1-BEND2 fusion. This case displays the limitations and pitfalls of a histological and immunohistochemical-based diagnosis in a case of an infrequently encountered pediatric brain tumor. Furthermore, it highlights the growing need for performing DNA methylation, paired with a comprehensive NGS panel, to ensure an accurate diagnosis in modern surgical neuropathology.

Original languageEnglish (US)
Pages (from-to)E1-E4
JournalAJSP: Reviews and Reports
Volume27
Issue number3
DOIs
StatePublished - May 1 2022

Keywords

  • BCOR
  • CNS tumor
  • DNA methylation
  • MN1-altered
  • astroblastoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Methylation Profiling Improves the Care of Pediatric Brain Tumor Patients'. Together they form a unique fingerprint.

Cite this